On a research trip up to a cemetery in Eldora, Amy Davis and Rikki Diana Pauley saw something strange in the night sky.

– Designation recognizes the potential of ETX101 to address a serious condition with high unmet need – Encoded Therapeutics, Inc. (“Encoded”), a clinical-stage biotechnology company developing ...

For more than 50 years, scientists have sought alternatives to silicon for building molecular electronics. The vision was elegant; the reality proved far more complex. Within a device, molecules ...

The odd phenomenon of quantum superposition has helped researchers break a fundamental quantum mechanical limit – and given quantum objects properties that make them useful for quantum computing for ...

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced positive ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Adrienne Maxwell Adrienne Maxwell is an editor covering AV gear. Her specialty ...

An unexpected revisit to my earlier post on mouse encoder hacking sparked a timely opportunity to reexamine quadrature encoders, this time with a clearer lens and a more targeted focus on their signal ...

Support multiple variants alphabet and padding: It is possible to use this module in other methods/ways which not listed in here, however those methods/ways are not officially supported, and should ...

Inspired by naturally occurring air bubbles in glaciers, researchers have developed a method to encode messages in ice. Publishing June 18 in the Cell Press journal Cell Reports Physical Science, the ...

William Wright receives funding from National Institutes of Health (NINDS) and the Schmidt Sciences. Takaki Komiyama receives funding from NIH, NSF, Simons Foundation, Chan Zuckerberg Initiative, and ...

Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy biotech draws resources away from its early-stage R&D toward its Dravet syndrome program. The asset in question, dubbed ...